Adrian joined Zoic in 2021 after graduating from the Harvard Chemical Biology Program, bringing over a decade of interdisciplinary technology experience to help with the firm’s stringent due diligence operations. His initial work examined the investment landscape in the post-pandemic era, identifying fields and technologies ripe for innovation where a strategic investor could find an edge, and scouting for seed-stage companies that fit this criteria.

Adrian now oversees new investments at Zoic, reviewing over 1000 health startups a year searching for the rare companies with the potential to transform their field, and supporting them in developing the mastery required to build their technology into an ecosystem. He leads investment committee meetings, identifying the most de-risked investment opportunities that fit the Zoic thesis, and manages the firm’s evolving investment strategy, conducting research modeling emerging technologies and characterizing signals of scientific revolution. As a patent practitioner, he works to develop and safeguard the intellectual property of the Zoic portfolio, leading IP strategy workshops for portfolio companies. He also supports startup mentoring network Creative Destruction Labs as a Scientific Advisor, assessing and assisting dozens of health startups. 

Adrian has a broad background in biotechnology and methods development research, and consults on technology and intellectual property strategy for startups, searching for poetry in the distillation of far-reaching ideas into simple principles. In his spare time Adrian enjoys composition, of both music and puzzles. He sings baritone in barbershop, and is an avid vegan chef and food science enthusiast.